litlas
Log inCreate account

Douglas E. Vaughan

Active 1987–2025

94
Papers
18,237
Citations
80
h-index
93
i10-index

Citations

Citations per year for Douglas E. Vaughan1964: 1 citations1982: 1 citations1988: 6 citations1989: 12 citations1990: 23 citations1991: 23 citations1992: 28 citations1993: 42 citations1994: 36 citations1995: 66 citations1996: 51 citations1997: 91 citations1998: 80 citations1999: 108 citations2000: 151 citations2001: 141 citations2002: 155 citations2003: 160 citations2004: 140 citations2005: 190 citations2006: 170 citations2007: 160 citations2008: 136 citations2009: 139 citations2010: 106 citations2011: 89 citations2012: 99 citations2013: 113 citations2014: 126 citations2015: 87 citations2016: 108 citations2017: 117 citations2018: 116 citations2019: 342 citations2020: 430 citations2021: 460 citations2022: 358 citations2023: 241 citations2024: 364 citations2025: 198 citations2026: 5 citations1965–1981: no citations, so these years are not shown1983–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,023 citing papers, 32.5% of this breakdownChina: 624 citing papers, 10% of this breakdownUnited Kingdom: 378 citing papers, 6.1% of this breakdownItaly: 294 citing papers, 4.7% of this breakdownGermany: 282 citing papers, 4.5% of this breakdownJapan: 253 citing papers, 4.1% of this breakdownCanada: 240 citing papers, 3.8% of this breakdownNetherlands: 187 citing papers, 3% of this breakdownFrance: 186 citing papers, 3% of this breakdownAustralia: 153 citing papers, 2.5% of this breakdownSpain: 135 citing papers, 2.2% of this breakdownSwitzerland: 97 citing papers, 1.6% of this breakdown
0%32.5%Other 22%

Institutions

Fields

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology25.6%
  • Immunology and Microbiology4.1%
  • Neuroscience2.4%
  • Nursing1%
  • Environmental Science0.7%
  • Other2.6%

Topics

  • Cardiac Fibrosis and Remodeling2.8%
  • Renin-Angiotensin System Studies2.7%
  • Protease and Inhibitor Mechanisms2.4%
  • Adipokines, Inflammation, and Metabolic Diseases2.4%
  • Hormonal Regulation and Hypertension2.2%
  • Blood Coagulation and Thrombosis Mechanisms2%
  • Other85.5%

Coauthors

All papers

Open in search
  1. Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction

    Authors: Elaine Y. Wan, Xin Yi Yeap, Shirley Dehn, Rachael Terry, Margaret L. Novak, Shuang Zhang, Shinichi Iwata, Xiaoqiang Han, Shunichi Homma, Konstantinos Drosatos, Jon W. Lomasney, David M. Engman, Stephen D. Miller, Douglas E. Vaughan, John Morrow, Raj Kishore, Edward B. Thorp - Circulation Research 2013 cited by 381

  2. Molecular and physiological manifestations and measurement of aging in humans

    Authors: Sadiya S. Khan, Benjamin D. Singer, Douglas E. Vaughan - Aging Cell 2017 cited by 514

  3. PAI‐1 in tissue fibrosis

    Authors: Asish K. Ghosh, Douglas E. Vaughan - Journal of Cellular Physiology 2011 cited by 681

  4. Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence

    Authors: Douglas E. Vaughan, Rahul Rai, Sadiya S. Khan, Mesut Eren, Asish K. Ghosh - Arteriosclerosis Thrombosis and Vascular Biology 2017 cited by 263

  5. Angiotensin-Converting Enzyme Inhibitors

    Authors: Nancy J. Brown, Douglas E. Vaughan - Circulation 1998 cited by 940

  6. MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis

    Authors: Varun Nagpal, Rahul Rai, Aaron T. Place, Sheila B. Murphy, Suresh K Verma, Asish K. Ghosh, Douglas E. Vaughan - Circulation 2016 cited by 256

  7. Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function

    Authors: Zhiyong Lin, Ajay Kumar, Sucharita SenBanerjee, Kristine E. Staniszewski, Kush M. Parmar, Douglas E. Vaughan, Michael A. Gimbrone, Viji Balasubramanian, Guillermo García‐Cardeña, Mukesh K. Jain - Circulation Research 2005 cited by 387

  8. Glycine supplementation extends lifespan of male and female mice

    Authors: Richard A. Miller, David E. Harrison, Clinton M. Astle, Molly A. Bogue, Joel Brind, Elizabeth Fernández, Kevin Flurkey, Martin A. Javors, Warren Ladiges, Christiaan Leeuwenburgh, Francesca Macchiarini, James F. Nelson, Alexey G. Ryazanov, Jessica M. Snyder, Timothy M. Stearns, Douglas E. Vaughan, Randy Strong - Aging Cell 2019 cited by 94

  9. Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor–Dependent Mechanism

    Authors: James M. Luther, James V. Gainer, Laine J. Murphey, Chang Yu, Douglas E. Vaughan, Jason D. Morrow, Nancy J. Brown - Hypertension 2006 cited by 166

  10. A null mutation in SERPINE1 protects against biological aging in humans

    Authors: Sadiya S. Khan, Sanjiv J. Shah, Ekaterina Klyachko, Abigail S. Baldridge, Mesut Eren, Aaron T. Place, Abraham Aviv, Eli Puterman, Donald M. Lloyd‐Jones, Meadow Heiman, Toshio Miyata, Sweta Gupta, Amy D. Shapiro, Douglas E. Vaughan - Science Advances 2017 cited by 155

  11. DNA Damage: A Main Determinant of Vascular Aging

    Authors: Paula K. Bautista‐Niño, Eliana Portilla-Fernández, Douglas E. Vaughan, A.H. Jan Danser, Anton J.M. Roks - International Journal of Molecular Sciences 2016 cited by 95

  12. PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice

    Authors: Mesut Eren, Amanda E. Boe, Sheila B. Murphy, Aaron T. Place, Varun Nagpal, Luisa Morales‐Nebreda, Daniela Urich, Susan E. Quaggin, G. R. Scott Budinger, Gökhan M. Mutlu, Toshio Miyata, Douglas E. Vaughan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 175

  13. Role of PAI-1 in hepatic steatosis and dyslipidemia

    Authors: Joshua A. Levine, Carlota Oleaga, Mesut Eren, Ansel P. Amaral, Meng Shang, Elizabeth Lux, Sadiya S. Khan, Sanjiv J. Shah, Yasuhiro Omura, Nathalie Pamir, Joshua Hay, Grant D. Barish, Toshio Miyata, Hagai Tavori, Sergio Fazio, Douglas E. Vaughan - Scientific Reports 2021 cited by 109

  14. Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan

    Authors: Rahul Rai, Asish K. Ghosh, Mesut Eren, Alexander R Mackie, Daniel C. Levine, So‐Youn Kim, Jonathan Cedernaes, Veronica Ramirez, Daniele Procissi, Layton H. Smith, Teresa K. Woodruff, Joseph Bass, Douglas E. Vaughan - Cell Reports 2017 cited by 87

  15. Acetyltransferase p300 inhibitor reverses hypertension‐induced cardiac fibrosis

    Authors: Rahul Rai, Tianjiao Sun, Veronica Ramirez, Elizabeth Lux, Mesut Eren, Douglas E. Vaughan, Asish K. Ghosh - Journal of Cellular and Molecular Medicine 2019 cited by 71

  16. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity

    Authors: Bart M. De Taeye, Tatiana Novitskaya, Owen P. McGuinness, Linda A. Gleaves, Mousumi Medda, Joseph W. Covington, Douglas E. Vaughan - American Journal of Physiology-Endocrinology and Metabolism 2007 cited by 208

  17. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis

    Authors: Panagiotis Flevaris, Sadiya S. Khan, Mesut Eren, Adam J.T. Schuldt, Sanjiv J. Shah, Daniel Lee, Sweta Gupta, Amy D. Shapiro, Paul W. Burridge, Asish K. Ghosh, Douglas E. Vaughan - Circulation 2017 cited by 91

  18. Inequalities in urban greenness and epigenetic aging: Different associations by race and neighborhood socioeconomic status

    Authors: Kyeezu Kim, Brian Joyce, Drew R. Nannini, Yinan Zheng, Penny Gordon‐Larsen, James M. Shikany, Donald M. Lloyd‐Jones, Ming Hu, Mark Nieuwenhuijsen, Douglas E. Vaughan, Kai Zhang, Lifang Hou - Science Advances 2023 cited by 55

  19. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis

    Authors: Panagiotis Flevaris, Douglas E. Vaughan - Seminars in Thrombosis and Hemostasis 2016 cited by 157

  20. PAI‐1 and atherothrombosis

    Authors: Douglas E. Vaughan - Journal of Thrombosis and Haemostasis 2005 cited by 515

  21. Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates N ω -Nitro- l -Arginine Methyl Ester–Induced Hypertension and Vascular Senescence

    Authors: Amanda E. Boe, Mesut Eren, Sheila B. Murphy, Christine Kamide, Atsuhiko Ichimura, David Terry, Danielle McAnally, Layton H. Smith, Toshio Miyata, Douglas E. Vaughan - Circulation 2013 cited by 132

  22. Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction

    Authors: Jay H. Traverse, Timothy D. Henry, Carl J. Pepine, James T. Willerson, David Zhao, Stephen G. Ellis, John R. Forder, R. David Anderson, Antonis K. Hatzopoulos, Marc S. Penn, Emerson C. Perin, Jeffrey Chambers, Kenneth W. Baran, Ganesh Raveendran, Charles Lambert, Amir Lerman, Daniel I. Simon, Douglas E. Vaughan, Dejian Lai, Adrian P. Gee, Doris A. Taylor, Christopher R. Cogle, James D. Thomas, Rachel Olson, Sherry Bowman, Judy Francescon, Carrie Geither, Eileen Handberg, Casey Kappenman, Lynette Westbrook, Linda B. Piller, Lara M. Simpson, Sarah Baraniuk, Cătălin Loghin, David Aguilar, Sara Richman, Claudia Zierold, Daniel B. Spoon, Judy Bettencourt, Shelly L. Sayre, Rachel W. Vojvodic, Sonia I. Skarlatos, David J. Gordon, Ray F. Ebert, Minjung Kwak, Lemuel A. Moyé, Robert D. Simari - JAMA 2012 cited by 388

  23. Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1

    Authors: Li-Jun Ma, Su-Li Mao, Kevin Taylor, Talerngsak Kanjanabuch, Youfei Guan, Ya-Hua Zhang, Nancy J. Brown, Larry L. Swift, Owen P. McGuinness, David H. Wasserman, Douglas E. Vaughan, Agnes B. Fogo - Diabetes 2004 cited by 399

  24. A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence

    Authors: Asish K. Ghosh, Rahul Rai, Kitae E. Park, Mesut Eren, Toshio Miyata, Lisa D. Wilsbacher, Douglas E. Vaughan - Oncotarget 2016 cited by 92